Dr. Shawnbir S. Gogia, MD

Dr. Gogia practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Gogia's NPI, 1467834697, was assigned on June 24, 2015. Dr. Gogia graduated from UCSF School of Medicine in 2015. Dr. Gogia holds California license A175821.

Dr. Gogia's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Gogia's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Gogia is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Gogia to 2 more hospitals, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gogia practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gogia's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Gogia's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Gogia treats.

CMS data shows 1,887 Medicare services from Dr. Gogia across 17 procedure codes in 2024, for 1,068 Medicare patients. Medicare paid $78,871 for them.

CMS counts 1,068 Medicare patients who saw Dr. Gogia in 2024. The largest group is 65 to 74, with 462 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gogia's median patient age at 64, with 38% women.

In 2024, Dr. Gogia wrote 239 Medicare Part D claims for 64 patients. 95% of them were for generic drugs. CMS names the drug for 182 of them, across 7 drugs with 11 or more claims each, at $1,346 in total drug cost. In 2023, CMS named 34 claims across 1 drug.

Dr. Gogia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gogia as offering telehealth. CMS counts 31 procedures of coronary angioplasty and stenting by Dr. Gogia, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Gogia, published from 2021 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Coronary Angiography. Dr. Gogia's most frequent co-authors are Ajay J. Kirtane, MD, Torsten Peter Vahl, MD and Ori Ben-Yehuda, MD.

CMS Open Payments shows 561 general payments to Dr. Gogia from 24 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $16,151.

Dr. Gogia graduated from UCSF School of Medicine in 2015.